Tag:
GrowthWorks
Latest Headlines
Latest Headlines
Ambit bounces back from dropped IPO with $30M round
A day after word that Ambit Biosciences had dropped plans for an $86 million IPO, venture investors have swooped in and replenished the cancer drug developer's coffers with a $30 million equity
